e-learning
resources
Barcelona 2010
Monday, 20.09.2010
Mechanical ventilation and weaning
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Heliox administration in patients with COPD exacerbation – Technical aspects
R. Zazula, K. Roubík, T. Tyll, M. Müller, V. Zábrodský, J. Chlumský, A. Strnadová, A. Spálený (Prague, Czech Republic)
Source:
Annual Congress 2010 - Mechanical ventilation and weaning
Session:
Mechanical ventilation and weaning
Session type:
E-Communication Session
Number:
2233
Disease area:
Airway diseases, Respiratory critical care
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Zazula, K. Roubík, T. Tyll, M. Müller, V. Zábrodský, J. Chlumský, A. Strnadová, A. Spálený (Prague, Czech Republic). Heliox administration in patients with COPD exacerbation – Technical aspects. Eur Respir J 2010; 36: Suppl. 54, 2233
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Symptoms experienced by COPD patients during exacerbations and their association with healthcare utilization – EXACO study
Source: Annual Congress 2011 - Respiratory epidemiology: quality of life, therapy and socioeconomics
Year: 2011
Efficacy of administration of 0.02% solution of decamethoxine via nebulizer in patients with infectious exacerbations of COPD
Source: Annual Congress 2013 –COPD treatment
Year: 2013
Predictors of PAO
2
and PaCO
2
in COPD patients
Source: Annual Congress 2009 - Gas exchange and exercise in respiratory diseases
Year: 2009
Halotherapy – A possible method to enhance airway treatment on patients with obstructive pathology
Source: Annual Congress 2012 - Treatment of asthma, bronchiectasis and cough: inhaler use
Year: 2012
Respiratory muscle function during and after a severe exacerbation of COPD – Preliminary results
Source: Annual Congress 2011 - Respiratory physiotherapy in the intensive care unit and on the ward: breathing exercises and respiratory muscles
Year: 2011
Mukoregulatory drugs in treating COPD
Source: International Congress 2014 – Predictors
Year: 2014
Comorbidities associated with chronic obstructive pulmonary disease (COPD) – A clinical study
Source: Annual Congress 2011 - COPD diagnosis
Year: 2011
Roflumilast added to triple therapy in severe COPD patients with frequent exacerbations: Efficacy and tolerability
Source: International Congress 2014 – Markers
Year: 2014
Characteristics of patients with chronic obstructive pulmonary disease (COPD) discharged from the emergency department – Improving the care pathway for acute exacerbations of COPD
Source: Annual Congress 2011 - COPD exacerbation
Year: 2011
Erdosteine improves airflow in patients with severe exacerbation of COPD (AECOPD)
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016
Impact of frequent exacerbations in patients with COPD
Source: International Congress 2014 – Clinical presentations
Year: 2014
Intractable breathlessness in COPD – A suitable case for palliation
Source: Annual Congress 2010 - Pharmacological treatment in primary care
Year: 2010
The relationship between 24-hour symptoms and COPD exacerbations: Results from ASSESS
Source: International Congress 2014 – COPD exacerbations
Year: 2014
Intractable breathlessness in COPD – A suitable case for palliation?
Source: Annual Congress 2011 - Quality of life and respiratory symptom management in primary care
Year: 2011
Diagnosing COPD and asthma in primary care in Israel – The challenge and the change
Source: Annual Congress 2011 - Integrated care and telehealth in primary care
Year: 2011
Oral glucocorticoid treatment of severe asthma – Current practice in the US
Source: Annual Congress 2010 - Aspects of severe asthma
Year: 2010
Exacerbations in patients with chronic obstructive lung disease (COPD) and concomitant asthma
Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease?
Year: 2014
Living with chronic obstructive pulmonary disease (COPD) – A lifeworld perspective
Source: Annual Congress 2010 - The nursing challenges and strategies when caring for patients with chronic lung disease
Year: 2010
Impact of mucolytic treatment on COPD exacerbations
Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation
Year: 2013
High-dose N-acetylcysteine in the prevention of COPD exacerbations: Results of the PANTHEON study
Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept